To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy

NCT00120328 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2364
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Speedel Pharma Ltd.